Back to
Susquehanna International Group, LLP
VIVO
Showing 0 of 15 quarters
Position history for
Susquehanna International Group, LLP's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Susquehanna International Group held 18,318 shares of VIVO (Meridian Bioscience), worth $608,341. Susquehanna International Group's 13F filings listed VIVO from Q3 2022 to Q4 2022, 2 quarterly filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.